Effect of Intravenous Dexmedetomidine During General Anesthesia on Acute Postoperative Pain in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The Clinical Journal of Pain
Xiuqin WangChuan Ding

Abstract

Dexmedetomidine has been shown to have an analgesic effect. However, no consensus was reached in previous studies. Electronic databases such as PubMed, Embase, and Cochrane Central were searched for relevant randomized controlled trials. The relative risk and weighted mean difference (WMD) were used to analyze the outcomes. Random-effects model was used for meta-analysis. Compared with the normal saline group, patients using DEX showed a significantly decreased pain intensity within 6 hours [WMD=-0.93; 95% confidence interval (CI), -1.34 to -0.53) and at 24 hours after surgery (WMD=-0.47; 95% CI, -0.83 to -0.11). DEX usage significantly reduced the cumulative opioids consumption at 24 hours after surgery (WMD=-6.76; 95% CI, -10.16 to -3.35), decreased the rescue opioids consumption in postanesthesia care unit (WMD=-3.11; 95% CI, -5.20 to -1.03), reduced the risk of rescue analgesics (relative risk=0.49; 95% CI, 0.33-0.71), and the interval to first rescue analgesia was prolonged (WMD=34.93; 95% CI, 20.27-49.59). Intravenous DEX effectively relieved the pain intensity, extended the pain-free period, and decreased the consumption of opioids during postoperative recovery of adults in general anesthesia.

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Oct 23, 1997·The New England Journal of Medicine·R A Wiklund, S H Rosenbaum
Jun 22, 1999·Lancet·D B Carr, L C Goudas
Mar 24, 2000·Drugs·N BhanaK J McClellan
Jul 25, 2000·JAMA : the Journal of the American Medical Association·D M Phillips
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Apr 21, 2005·BMC Medical Research Methodology·Stela Pudar HozoIztok Hozo
Jun 29, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Alp GurbetBerin Ozcan
Oct 7, 2006·The Tohoku Journal of Experimental Medicine·Zerrin OzkoseSahin Yardim
Jan 24, 2007·European Journal of Anaesthesiology·M DurmusM O Ersoy
Feb 15, 2007·The Annals of Pharmacotherapy·Anthony T Gerlach, Joseph F Dasta
Jan 22, 2008·European Journal of Anaesthesiology·E G ElvanU Aypar
May 6, 2008·BMJ : British Medical Journal·Gordon H GuyattUNKNOWN GRADE Working Group
May 24, 2008·Anesthesia and Analgesia·Burcu TufanogullariDavid A Provost
Sep 23, 2008·Anesthesia and Analgesia·Alex BekkerAbishabeck Pitti
Oct 4, 2008·International Journal of Epidemiology·Julian P T Higgins
Jul 17, 2009·Current Opinion in Anaesthesiology·Asokumar Buvanendran, Jeffrey S Kroin
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Nov 26, 2009·The Annals of Pharmacotherapy·Anthony T GerlachJoseph F Dasta
Jul 20, 2010·BMJ : British Medical Journal·Eveline NüeschPeter Jüni
Mar 2, 2011·British Journal of Anaesthesia·J ZhangY Wang
Jun 28, 2011·Lancet·Christopher L Wu, Srinivasa N Raja
Oct 31, 2012·Seminars in Cardiothoracic and Vascular Anesthesia·Mohamed A Khalil, Mohsen S Abdel Azeem
Dec 1, 2012·Korean journal of anesthesiology·Jung-Kyu ParkHyun-Tae Kim
Dec 28, 2012·Critical Care Medicine·Juliana BarrUNKNOWN American College of Critical Care Medicine
May 7, 2013·Korean journal of anesthesiology·Cheol LeeJi-Na Kim
Jul 23, 2013·British Journal of Anaesthesia·F EspitalierB Giraudeau
Aug 29, 2013·International Journal of Medical Sciences·Yong-Shin KimHye-Rim Kang
Jan 31, 2014·The New England Journal of Medicine·Michael C Reade, Simon Finfer
Aug 19, 2014·Acta Anaesthesiologica Scandinavica·S Y HamY H Shim
Dec 3, 2014·The Journal of Surgical Research·Yulan WangFuhai Ji
Mar 15, 2015·Clinical Therapeutics·Ke PengFu-hai Ji

❮ Previous
Next ❯

Citations

Mar 9, 2019·Journal of Pharmacy Practice·Chelsea R Wampole, Kathryn E Smith
Feb 2, 2019·Frontiers in Psychiatry·Seyed A Safavynia, Peter A Goldstein
Nov 20, 2019·Anesthesia and Analgesia·Amanda M Kleiman, Ken B Johnson
Nov 15, 2021·Journal of Clinical Pharmacology·Kathryn SmithAurora Quaye

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Software Mentioned

Excel
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.